Low-dose Magnesium Sulfate Versus High Dose in the Early Management of Rapid Atrial Fibrillation: Randomized Controlled Double-blind Study (LOMAGHI Study)

Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
Wahid BouidaSemir Nouira

Abstract

We aim to determine the benefit of two different doses magnesium sulfate (MgSO4 ) compared to placebo in rate control of rapid atrial fibrillation (AF) managed in the emergency department (ED). We undertook a randomized, controlled, double-blind clinical trial in three university hospital EDs between August 2009 and December 2014. Patients > 18 years with rapid AF (>120 beats/min) were enrolled and randomized to 9 g of intravenous MgSO4 (high-dose group, n = 153), 4.5 g of intravenous MgSO4 (low-dose group, n = 148), or serum saline infusion (placebo group, n = 149), given in addition to atrioventricular (AV) nodal blocking agents. The primary outcome was the reduction of baseline ventricular rate (VR) to 90 beats/min or less or reduction of VR by 20% or greater from baseline (therapeutic response). Secondary outcome included resolution time (defined as the elapsed time from start of treatment to therapeutic response), sinus rhythm conversion rate, and adverse events within the first 24 hours. At 4 hours, therapeutic response rate was higher in low- and high-MgSO4 groups compared to placebo group; the absolute differences were, respectively, 20.5% (risk ratio [RR] = 2.31, 95% confidence interval [CI] = 1.45-3.69) and +15.8% (RR...Continue Reading

References

Jul 1, 1984·American Heart Journal·L T Iseri, J H French
Jul 1, 1994·Annals of Emergency Medicine·J V HaysB J Rubal
Jun 15, 1994·The American Journal of Cardiology·M A BrodskyY S Orlov
Feb 7, 2001·Chest·G W AlbersD E Singer
Feb 24, 2001·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·E H ChristiansenA K Pedersen
Feb 24, 2001·Critical Care Clinics·M S Agus, Z S Agus
Jul 20, 2001·International Journal of Cardiology·J A ChiladakisA S Manolis
Aug 12, 2004·Pharmacotherapy·Alexandria A Piotrowski, James S Kalus
Mar 11, 2006·European Heart Journal·Jan HeeringaJacqueline C M Witteman
Jun 15, 2007·The American Journal of Cardiology·Orhan OnalanIlan Lashevsky
Feb 12, 2009·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Kevin ChuAnthony Brown

❮ Previous
Next ❯

Citations

May 16, 2019·Emergency Medicine Australasia : EMA·Nick Adams
Sep 27, 2020·Antioxidants·Man Liu, Samuel C Dudley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.